NO973624L - Vasokonstriktive substituerte 2,3-dihydro-1,4-dioksinopiperidiner - Google Patents

Vasokonstriktive substituerte 2,3-dihydro-1,4-dioksinopiperidiner

Info

Publication number
NO973624L
NO973624L NO973624A NO973624A NO973624L NO 973624 L NO973624 L NO 973624L NO 973624 A NO973624 A NO 973624A NO 973624 A NO973624 A NO 973624A NO 973624 L NO973624 L NO 973624L
Authority
NO
Norway
Prior art keywords
vasoconstrictively
dioxinopiperidines
dihydro
substituted
vasoconstrictively substituted
Prior art date
Application number
NO973624A
Other languages
English (en)
Other versions
NO315237B1 (no
NO973624D0 (no
Inventor
Guy Rosalia Eugene Van Lommen
Jose Ignacio Andres-Gil
Francisco Javi Fernandez-Gadea
Maria Enc Matesanz-Ballesteros
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO973624D0 publication Critical patent/NO973624D0/no
Publication of NO973624L publication Critical patent/NO973624L/no
Publication of NO315237B1 publication Critical patent/NO315237B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO19973624A 1995-02-07 1997-08-06 Vasokonstriktive substituerte 2,3-dihydro-1,4- dioksinopiperidiner NO315237B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200290 1995-02-07
PCT/EP1996/000396 WO1996024596A1 (en) 1995-02-07 1996-01-30 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines

Publications (3)

Publication Number Publication Date
NO973624D0 NO973624D0 (no) 1997-08-06
NO973624L true NO973624L (no) 1997-08-06
NO315237B1 NO315237B1 (no) 2003-08-04

Family

ID=8219997

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973624A NO315237B1 (no) 1995-02-07 1997-08-06 Vasokonstriktive substituerte 2,3-dihydro-1,4- dioksinopiperidiner

Country Status (16)

Country Link
US (1) US5990123A (no)
EP (1) EP0808316B9 (no)
JP (1) JP4093431B2 (no)
KR (1) KR100412070B1 (no)
AR (1) AR002959A1 (no)
AT (1) ATE263170T1 (no)
AU (1) AU692361B2 (no)
DE (1) DE69632032T2 (no)
ES (1) ES2218582T3 (no)
FI (1) FI113774B (no)
IL (1) IL117045A (no)
MY (1) MY113426A (no)
NO (1) NO315237B1 (no)
TW (1) TW446706B (no)
WO (1) WO1996024596A1 (no)
ZA (1) ZA96933B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6656950B2 (en) 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
US6821981B2 (en) 2001-04-26 2004-11-23 Wyeth Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]-quinoline as 5-HT1A antagonists
WO2004106298A1 (en) * 2003-05-30 2004-12-09 Janssen Pharmaceutica N.V. Indole derivatives with an improved antipsychotic activity
EP1805142A4 (en) * 2004-09-23 2009-06-10 Reddy Us Therapeutics Inc PYRIDINE-BASED COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254496B (it) * 1992-03-05 1995-09-25 Enichem Spa Preparazione di copolimeri alternati olefine/ossido di carbonio per mezzo di un catalizzatore eterogeneo supportato
ZA931343B (en) * 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
DE4226527A1 (de) * 1992-08-11 1994-02-17 Merck Patent Gmbh 1,4-Benzodioxanderivate

Also Published As

Publication number Publication date
FI113774B (fi) 2004-06-15
ZA96933B (en) 1997-08-06
ATE263170T1 (de) 2004-04-15
FI973245A0 (fi) 1997-08-06
IL117045A (en) 1999-03-12
KR19980701921A (ko) 1998-06-25
MY113426A (en) 2002-02-28
AU4785696A (en) 1996-08-27
TW446706B (en) 2001-07-21
JPH10513460A (ja) 1998-12-22
NO315237B1 (no) 2003-08-04
EP0808316A1 (en) 1997-11-26
FI973245L (fi) 1997-08-06
EP0808316B1 (en) 2004-03-31
JP4093431B2 (ja) 2008-06-04
WO1996024596A1 (en) 1996-08-15
EP0808316B9 (en) 2004-12-01
AR002959A1 (es) 1998-05-27
NO973624D0 (no) 1997-08-06
KR100412070B1 (ko) 2004-05-24
IL117045A0 (en) 1996-06-18
DE69632032D1 (de) 2004-05-06
AU692361B2 (en) 1998-06-04
DE69632032T2 (de) 2005-03-10
US5990123A (en) 1999-11-23
ES2218582T3 (es) 2004-11-16

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
MA23780A1 (fr) Quinazolinones 2, 8 disubstitues
FI954651A7 (fi) Mahdollisesti substituoidut 6,8-kinoliinit
DK0771789T3 (da) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
DE69618634D1 (de) 1,4-benzodioxin-derivate
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
EP0811014A4 (en) NEW BACTERIOCINE, PISCICOLIN 126
NO973624D0 (no) Vasokonstriktive substituerte 2,3-dihydro-1,4-dioksinopiperidiner
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
ES1032571Y (es) Gafa,
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
ITMI941593A1 (it) Tetraidropiridine 3, 3-disostituite
IT1283187B1 (it) "elettrovalvola."

Legal Events

Date Code Title Description
MK1K Patent expired